business

Novartis AG (NVS) states Rare Muscle Disease Drug Shows Promise in Early Trial

Yahoo Finance · Jun 23, 2026, 7:51 PM · Also reported by 2 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Pfizer dismissed from US states’ drug price-fixing lawsuit The Hindu A.P. to strengthen care for rare disease patients, says Health Minister

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Novartis AG (NVS) states Rare Muscle Disease Drug Shows Promise in Early Trial

Also covered by

More in business